BETA CAT PHARMACEUTICALS INC has a total of 12 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2016. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are VUAB PHARMA A S, SUFFREN STE PARTI BREVETS and BEIJING FSWELCOME TECHNOLOGY DEV CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Reddy Seelam Venkata | 9 |
#2 | Sharma Sunil | 9 |
#3 | Liu Xiaohui | 9 |
#4 | Kasibhatla Srinivas | 8 |
#5 | Vankayalapati Hariprasad M | 7 |
#6 | Vankayalapati Hariprasad | 2 |
#7 | Northrup Jon | 2 |
#8 | Han Ruolan | 2 |
#9 | Larson Jeff | 2 |
#10 | Kasibhatla Srinivas Rao | 2 |
Publication | Filing date | Title |
---|---|---|
WO2018223023A1 | Methods for treatment of fibrotic diseases | |
US2017334936A1 | Anthracene-9, 10-dione dioxime compound prodrugs and their uses | |
US2017029450A1 | Anthracene-9, 10-dione dioxime compound prodrugs and their uses |